TB Research

Efficacy of short‐term intravenous clindamycin prior to oral clindamycin–rifampicin treatment in hidradenitis suppurativa: a retrospective case series

Georgios Nikolakis, Anna Kristandt, Michael Hauptmann, Markus Becker, Christos C. Zouboulis

British Journal of Dermatology · 2021-07

Abstract

antibiotics represent the first-line hidradenitis suppurativa (HS) treatment, although HS is not an infectious disease1 . Prolonged antibiotic courses exhibit an anti-inflammatory effect, utilized for treating follicular/inflammatory skin diseases, e.g. acne and rosacea. Clindamycin/rifampicin or tetracyclines are usually administered for 10 to 12 weeks in moderate-to-severe HS treatment1 , mostly based on retrospective studies using non-validated severity scoring systems.

MeSH terms

  • Hidradenitis suppurativa
  • Clindamycin
  • Medicine
  • Rifampicin
  • Rosacea
  • Acne
  • Antibiotics
  • Dermatology
  • Retrospective cohort study
  • Internal medicine